Basiliximab is an -

Basiliximab is an -
a) IL-1 receptor antagonist
b) Anti-CD3 antibody
c) IL-2 receptor antagonist
d) TNF inhibitor
Correct Answer - C
Answer:- C - IL-2 receptor antagonist
Basiliximab exhibits high affinity towards IL-2 receptor,
inhibiting it.
Anti- CD-25 antibody
High affinity for IL-2 receptor
Short plasma half life - 1 week
Useful in preventing transplant rejection reactions.
Adverse effects - Anaphylactic reactions & opportunistic infections.